Your browser doesn't support javascript.
loading
Association Between Insulin Resistance and Cardiovascular Disease Risk Varies According to Glucose Tolerance Status: A Nationwide Prospective Cohort Study.
Wang, Tiange; Li, Mian; Zeng, Tianshu; Hu, Ruying; Xu, Yu; Xu, Min; Zhao, Zhiyun; Chen, Yuhong; Wang, Shuangyuan; Lin, Hong; Yu, Xuefeng; Chen, Gang; Su, Qing; Mu, Yiming; Chen, Lulu; Tang, Xulei; Yan, Li; Qin, Guijun; Wan, Qin; Gao, Zhengnan; Wang, Guixia; Shen, Feixia; Luo, Zuojie; Qin, Yingfen; Chen, Li; Huo, Yanan; Li, Qiang; Ye, Zhen; Zhang, Yinfei; Liu, Chao; Wang, Youmin; Wu, Shengli; Yang, Tao; Deng, Huacong; Zhao, Jiajun; Shi, Lixin; Ning, Guang; Bi, Yufang; Wang, Weiqing; Lu, Jieli.
Affiliation
  • Wang T; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Li M; Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, State Key Laboratory for Endocrine and Metabolic Diseases, State Key Laboratory for Endocrine Tumor, State Key Laboratory for Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
  • Zeng T; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Hu R; Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, State Key Laboratory for Endocrine and Metabolic Diseases, State Key Laboratory for Endocrine Tumor, State Key Laboratory for Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
  • Xu Y; Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Xu M; Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
  • Zhao Z; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Chen Y; Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, State Key Laboratory for Endocrine and Metabolic Diseases, State Key Laboratory for Endocrine Tumor, State Key Laboratory for Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
  • Wang S; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Lin H; Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, State Key Laboratory for Endocrine and Metabolic Diseases, State Key Laboratory for Endocrine Tumor, State Key Laboratory for Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
  • Yu X; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Chen G; Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, State Key Laboratory for Endocrine and Metabolic Diseases, State Key Laboratory for Endocrine Tumor, State Key Laboratory for Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
  • Su Q; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Mu Y; Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, State Key Laboratory for Endocrine and Metabolic Diseases, State Key Laboratory for Endocrine Tumor, State Key Laboratory for Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
  • Chen L; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Tang X; Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, State Key Laboratory for Endocrine and Metabolic Diseases, State Key Laboratory for Endocrine Tumor, State Key Laboratory for Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
  • Yan L; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Qin G; Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, State Key Laboratory for Endocrine and Metabolic Diseases, State Key Laboratory for Endocrine Tumor, State Key Laboratory for Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
  • Wan Q; Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Gao Z; Fujian Provincial Hospital, Fujian Medical University, Fuzhou, China.
  • Wang G; Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Shen F; Chinese People's Liberation Army General Hospital, Beijing, China.
  • Luo Z; Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Qin Y; The First Hospital of Lanzhou University, Lanzhou, China.
  • Chen L; Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Huo Y; The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Li Q; The Affiliated Hospital of Southwest Medical University, Luzhou, China.
  • Ye Z; Dalian Municipal Central Hospital, Dalian, China.
  • Zhang Y; The First Hospital of Jilin University, Changchun, China.
  • Liu C; The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Wang Y; The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Wu S; The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Yang T; Qilu Hospital of Shandong University, Jinan, China.
  • Deng H; Jiangxi Provincial People's Hospital Affiliated to Nanchang University, Nanchang, China.
  • Zhao J; The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Shi L; Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
  • Ning G; Central Hospital of Shanghai Jiading District, Shanghai, China.
  • Bi Y; Jiangsu Province Hospital on Integration of Chinese and Western Medicine, Nanjing, China.
  • Wang W; The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Lu J; Karamay Municipal People's Hospital, Xinjiang, China.
Diabetes Care ; 45(8): 1863-1872, 2022 08 01.
Article in En | MEDLINE | ID: mdl-35700159
ABSTRACT

OBJECTIVE:

To investigate whether the association between insulin resistance and cardiovascular disease (CVD) differs by glucose tolerance status. RESEARCH DESIGN AND

METHODS:

We analyzed a nationwide sample of 111,576 adults without CVD at baseline, using data from the China Cardiometabolic Disease and Cancer Cohort Study. Insulin resistance was estimated by sex-specific HOMA of insulin resistance (HOMA-IR) quartiles for participants with normal glucose tolerance, prediabetes, or diabetes, separately, and by 1 SD of HOMA-IR for the overall study participants. We used Cox proportional hazards models to examine the association between insulin resistance and incident CVD according to glucose tolerance status and evaluate the CVD risk associated with the combined categories of insulin resistance and obesity in prediabetes and diabetes, as compared with normal glucose tolerance. Models were adjusted for age, sex, education attainment, alcohol drinking, smoking, physical activity, and diet quality.

RESULTS:

In participants with normal glucose tolerance, prediabetes, and diabetes defined by three glucose parameters, multivariable-adjusted hazard ratios (95% CIs) for incident CVD associated with the highest versus the lowest quartile of HOMA-IR were 1.03 (0.82-1.30), 1.23 (1.07-1.42), and 1.61 (1.30-2.00), respectively; the corresponding values for CVD per 1-SD increase in HOMA-IR were 1.04 (0.92-1.18), 1.12 (1.06-1.18), and 1.15 (1.09-1.21), respectively (P for interaction = 0.011). Compared with participants with normal glucose tolerance, in participants with prediabetes, the combination of the highest HOMA-IR quartile and obesity showed 17% (95% CI 2-34%) higher risk of CVD, while the combination of the lowest two HOMA-IR quartiles and nonobesity showed 15-17% lower risk of CVD. In participants with diabetes, the upper two HOMA-IR quartiles exhibited 44-77% higher risk of CVD, regardless of obesity status. Consistent findings were observed for glucose tolerance status defined by different combinations of glycemic parameters.

CONCLUSIONS:

Glucose intolerance status exacerbated the association between insulin resistance and CVD risk. Compared with adults with normal glucose tolerance, adults with prediabetes who were both insulin resistant and obese exhibited higher risks of CVD, while in adults with diabetes, the CVD risk related to insulin resistance remained, regardless of obesity.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prediabetic State / Insulin Resistance / Cardiovascular Diseases / Diabetes Mellitus Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: Diabetes Care Year: 2022 Document type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prediabetic State / Insulin Resistance / Cardiovascular Diseases / Diabetes Mellitus Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: Diabetes Care Year: 2022 Document type: Article Affiliation country: China